Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.39 is 21% above its 1-year average of 7.78, around the middle of its 1-year range (0.00–13.94).
As of the fiscal period ended Tuesday, June 30, 2026. 19.54% below its 12-month average of 11.67.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.39.
CURRENT RATIO
9.39
CURRENT RATIO AVG TTM
11.67
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-19.54%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
+169.70%
vs the sector median at left
Attovia Therapeutics, Inc.
Market Cap
$780.99M
Current Ratio
9.39
TTM Avg
11.67
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$770.72M
Current Ratio
18.86
TTM Avg
23.23
3Y Avg
26.78
5Y Avg
32.61
Market Cap
$772.37M
Current Ratio
2.07
TTM Avg
1.18
3Y Avg
1.89
5Y Avg
3.24
Market Cap
$787.65M
Current Ratio
13.37
TTM Avg
5.16
3Y Avg
5.50
5Y Avg
4.90
Market Cap
$796.03M
Current Ratio
4.26
TTM Avg
4.46
3Y Avg
3.96
5Y Avg
4.08
Market Cap
$752.87M
Current Ratio
16.09
TTM Avg
8.04
3Y Avg
7.87
5Y Avg
9.13
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | $780.99M | 9.39 | 11.67 | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $770.72M | 18.86 | 23.23 | 26.78 | 32.61 |
| Mesa Laboratories, Inc. (MLAB)vs › | $772.37M | 2.07 | 1.18 | 1.89 | 3.24 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $787.65M | 13.37 | 5.16 | 5.50 | 4.90 |
| AdaptHealth Corp. (AHCO)vs › | $795.58M | 1.12 | 1.18 | 1.21 | 1.17 |
| Geron Corporation (GERN)vs › | $790.35M | 6.92 | 5.11 | 3.93 | 4.38 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $796.03M | 4.26 | 4.46 | 3.96 | 4.08 |
| Candel Therapeutics, Inc. (CADL)vs › | $752.87M | 16.09 | 8.04 | 7.87 | 9.13 |
| InMode Ltd. (INMD)vs › | $805.31M | 8.18 | 10.05 | 10.24 | 9.72 |
| Apnimed, Inc. (APMD)vs › | $807.61M | N/A | N/A | N/A | N/A |
Current Ratio
9.39
Quick Ratio
9.39
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.39 |
| 2026-03-31 | 13.94 |
| 2025-03-31 | 0.00 |
